These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19574655)

  • 1. Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.
    Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):739-42. PubMed ID: 19574655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
    Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19274-9. PubMed ID: 19880749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
    Xiang Y; de Groot R; Crawley JT; Lane DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.
    Zheng X; Nishio K; Majerus EM; Sadler JE
    J Biol Chem; 2003 Aug; 278(32):30136-41. PubMed ID: 12791682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric activation of ADAMTS13 by von Willebrand factor.
    Muia J; Zhu J; Gupta G; Haberichter SL; Friedman KD; Feys HB; Deforche L; Vanhoorelbeke K; Westfield LA; Roth R; Tolia NH; Heuser JE; Sadler JE
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18584-9. PubMed ID: 25512528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T; Hamako J
    Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13 and von Willebrand factor interactions.
    Zander CB; Cao W; Zheng XL
    Curr Opin Hematol; 2015 Sep; 22(5):452-9. PubMed ID: 26186678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of ADAMTS13 to von Willebrand factor.
    Majerus EM; Anderson PJ; Sadler JE
    J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of the disintegrin-like domain in ADAMTS13 function.
    de Groot R; Bardhan A; Ramroop N; Lane DA; Crawley JT
    Blood; 2009 May; 113(22):5609-16. PubMed ID: 19234142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.
    Gao W; Zhu J; Westfield LA; Tuley EA; Anderson PJ; Sadler JE
    J Biol Chem; 2012 Aug; 287(32):26944-52. PubMed ID: 22707719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.
    Ling J; Su J; Ma Z; Ruan C
    Thromb Res; 2013 Jun; 131(6):529-34. PubMed ID: 23683325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor.
    Ai J; Smith P; Wang S; Zhang P; Zheng XL
    J Biol Chem; 2005 Aug; 280(33):29428-34. PubMed ID: 15975930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and enzymatic activity of an ADAMTS-13 mutant with the East Asian-specific P475S polymorphism.
    Akiyama M; Nakayama D; Takeda S; Kokame K; Takagi J; Miyata T
    J Thromb Haemost; 2013 Jul; 11(7):1399-406. PubMed ID: 23621748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
    Jin SY; Skipwith CG; Zheng XL
    Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
    Xiao J; Jin SY; Xue J; Sorvillo N; Voorberg J; Zheng XL
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2261-9. PubMed ID: 21799176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.
    Gao W; Anderson PJ; Majerus EM; Tuley EA; Sadler JE
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19099-104. PubMed ID: 17146059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ADAMTS13, von Willebrand factor specific cleaving protease].
    Veyradier A; Coppo P
    Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.
    Tao Z; Peng Y; Nolasco L; Cal S; Lopez-Otin C; Li R; Moake JL; López JA; Dong JF
    Blood; 2005 Dec; 106(13):4139-45. PubMed ID: 16141351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.